Become A Sponsor
Stock Market | Kudrna's Stock Market Talk

Archive for the ‘Stock Market’ Category

avatar

Potential Trades This Week: Looking For Consolidation

Referencing the weekly homework and stock radar, I am highlighting a few of the below for in undervalued stocks.

We finally saw signs of consolidation this morning, but it was short-lived creating continued frustration for the bears.  The trend over the past few months has been that gap-ups tend to drift down towards the rest of the day and gap-downs tend to drift up the rest of the day.  Today continued that trend as we drifted back towards even on the day. (more…)

avatar

Weekly Traders Homework: Frustrated Bears (w/Economic Calendar & Stock Radar)

Another frustrating week for the bears.  Bears continue to pound their heads against the wall as nothing seems strong enough to take the markets down.  Weaker-than-expected GDP did not even phase the markets much on Friday.  With the keeping interest rates low until 2014 and reducing growth expectations in 2012, we not only have have a fragile economic recovery, but we are continuing to pressure the savers/retirees for at least a few more years. (more…)

avatar

BreakoutTrader: Nasdaq – Thursday Intraday Volume Support

The following 2-hour chart on QQQ shows buyers (volume)
come after QQQ went down to $59.93 area.
It is worthwhile to watch next week on 2-hour chart
to see if $60 area can hold. (more…)

avatar

BreakoutTrader: Nordstrom – Calm Before Earnings?

Stocks of , the high-end retailer, caught
our attention today (1/25) as one of the stocks that
generated a daily extreme breakout down signal.
The stock is down 1.8% today. (more…)

avatar

BreakoutTrader: Quick Charts – XLI Strong Uptrend

Annotated Chart for SPDR Select Sector Fund – Indus (XLI) Below:  (more…)

avatar

Biotech: Merck (MRK) C. difficile Program Notes From R&D Day

Ok last of this series of posts of interesting snippets from the recent Merck R&D day. See below for commentary and slides regarding their unique monoclonal antibody program for C. difficile associated diarrhea (CDAD). Important for those who follow Optimer OPTR and Cubist CBST, among others. I am working on a more complete analysis of the prospects for this MK3415A program, which is currently in phase 3 development. (more…)
avatar

Biotech: Biomarkers And The Future Of Cancer Drug Development

was emphasizing the importance of cancer biomarkers in the R&D day presentation. See the chart below for the pipeline programs, indication, and biomarker strategy. (more…)

avatar

Potential Trades w/Charts: Signs Of A Market Top?

Referencing the weekly homework and stock radar, I am highlighting a few of the below for in undervalued stocks.

On the outside, it may look like Monday was a flat day in the markets, but the underlying action was far more bullish than that view provides.  Bonds were weak again helping provide fuel for equities in the form of additional support and “ammo” for dip buyers to put to use.  If bonds continue to weaken this week, all of this talk of a market top forming will likely be far too early. (more…)

avatar

Canady: Bizarre Story Shows Continuing Strength Of Apple’s Appeal

Looking around at just about any modern city in the world you might be forgiven for thinking that has taken over the world. With literally millions of Iphones, Ipads, and Ipods being sold every month, Apple’s products are some of the most popular in the history of the world. Apple is in nearly every corner of the world as evidenced by its own website. Finally, the company became the largest in the world in terms of market cap back in August 2011.  (more…)

avatar

BreakoutTrader: Rating Cramer’s Game Plan – The Week Of 1/23/2012

The following is our review of some of the stocks
mentioned in Cramer’s game plan for the week
of 1/23.

The focus here is to identify each stock’s current state
in terms of its strength relative to the market, its
industry indexes and the trend. (more…)

More on this topic (What's this?) Read more on Jim Cramer at Wikinvest
Sponsor Ad

>